ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2087

Defective Regulation of L1 Endogenous Retroelements in Primary Sjogren’s Syndrome and Systemic Lupus Erythematosus: Role of Methylating Enzymes

Clio Mavragani1, Adrianos Nezos2, Irina Sagalovskiy3, Surya V. Seshan4, Kyriakos A. Kirou5, Haralampos M. Moutsopoulos6 and Mary K. Crow3, 1Department of Physiology, School of Medicine, University of Athens, Athens, Greece, 2Department of Physiology, School of Medicine, University of Athens, Athens, Greece, 3Department of Medicine, Hospital for Special Surgery, New York, NY, 4Pathology and Laboratory Medicine, Hospital for Special Surgery, New York, NY, 5Hospital for Special Surgery, New York, NY, 6Department of Pathophysiology, School of Medicine, University of Athens, Athens, Greece

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: methylation

  • Tweet
  • Email
  • Print
Session Information

Title: Genetics, Genomics and Proteomics

Session Type: Abstract Submissions (ACR)

Background/Purpose: To investigate whether deranged methylating mechanisms are involved in the inappropriate expression of LINE-1 (L1) retroelements in primary Sjogren’s syndrome (SS) and systemic lupus erythematosus (SLE). 

Methods: Minor salivary glands (MSG) were obtained from 35 patients with primary SS [23 without adverse predictors for lymphoma development (SS-low risk) and 12 complicated by B-cell lymphoma (SS-lymphoma)] and 17 sicca controls (SC). Additionally, kidney biopsy specimens and PBMCs were obtained from 23 and 73 lupus patients respectively. Relative mRNA expression was quantified for full-length L1 transcripts, along with mediators of methylation. In an independent set of 22 MSG samples (8 SS-low risk, 11 SS-lymphoma and 3 SC), methylation levels of the L1 promoter were determined by bisulphite pyrosequencing.

Results: A strong positive correlation was demonstrated between L1 transcripts and gene products that mediate de novo and constitutive DNA methylation, DNA methyltransferase (DNMT)3B, DNMT1, and methyl CpG binding protein 2 (MeCP2), in both SS MSG and lupus renal tissues. A significantly negative correlation was observed between expression of L1 and lymphoid-specific helicase (LSH, encoded by HELLS) in both SS MSG and SLE kidney tissues, as well as between DNMT3A transcripts and L1 expression in SLE kidney tissues and PBMCs. Reduced levels of L1 promoter methylation along with increased DNMT3B, DNMT1, and MeCP2, but reduced LSH levels were detected in SS-low risk patients compared to both SS-lymphoma and SC. The SS-lymphoma group was also characterized by a profound decrease of MeCP2 and DNMT3B compared to SC.

Conclusion: Our data support a contributory role of altered methylation mechanisms in the pathogenesis of systemic autoimmune disorders and related lymphoproliferative processes and suggest that LSH and DNMT3A should be investigated as candidate upstream mediators of decreased L1 promoter methylation and increased L1 expression.


Disclosure:

C. Mavragani,
None;

A. Nezos,
None;

I. Sagalovskiy,
None;

S. V. Seshan,
None;

K. A. Kirou,
None;

H. M. Moutsopoulos,
None;

M. K. Crow,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/defective-regulation-of-l1-endogenous-retroelements-in-primary-sjogrens-syndrome-and-systemic-lupus-erythematosus-role-of-methylating-enzymes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology